GW & Wade’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $8.76M | Sell |
106,314
-29,575
| -22% | -$2.25M | 0.28% | 78 |
|
|
2023
Q3 | $10.6M | Buy |
135,889
+6,819
| +5% | +$571K | 0.4% | 69 |
|
|
2023
Q2 | $11.4M | Sell |
129,070
-3,811
| -3% | -$328K | 0.41% | 67 |
|
|
2023
Q1 | $10.7M | Buy |
132,881
+7,605
| +6% | +$620K | 0.41% | 66 |
|
|
2022
Q4 | $9.74M | Sell |
125,276
-3,848
| -3% | -$312K | 0.4% | 68 |
|
|
2022
Q3 | $10.4M | Sell |
129,124
-1,256
| -1% | -$113K | 0.51% | 62 |
|
|
2022
Q2 | $11.7M | Buy |
130,380
+4,341
| +3% | +$440K | 0.53% | 57 |
|
|
2022
Q1 | $14M | Buy |
126,039
+4,915
| +4% | +$519K | 0.6% | 53 |
|
|
2021
Q4 | $12.5M | Buy |
121,124
+5,183
| +4% | +$600K | 0.54% | 59 |
|
|
2021
Q3 | $14.5M | Buy |
115,941
+77
| +0.1% | +$9.97K | 0.69% | 50 |
|
|
2021
Q2 | $14.4M | Buy |
115,864
+2,297
| +2% | +$288K | 0.69% | 48 |
|
|
2021
Q1 | $13.4M | Buy |
113,567
+3,333
| +3% | +$391K | 0.71% | 49 |
|
|
2020
Q4 | $12.9M | Buy |
110,234
+1,438
| +1% | +$158K | 0.79% | 43 |
|
|
2020
Q3 | $11.3M | Sell |
108,796
-339
| -0.3% | -$34K | 0.86% | 40 |
|
|
2020
Q2 | $10M | Buy |
109,135
+2,871
| +3% | +$275K | 0.82% | 40 |
|
|
2020
Q1 | $9.58M | Buy |
106,264
+166
| +0.2% | +$17.7K | 0.9% | 39 |
|
|
2019
Q4 | $12M | Buy |
106,098
+2,297
| +2% | +$252K | 0.92% | 34 |
|
|
2019
Q3 | $11.3M | Buy |
103,801
+2,898
| +3% | +$302K | 0.96% | 34 |
|
|
2019
Q2 | $9.83M | Buy |
100,903
+97,139
| +2,581% | +$8.87M | 0.89% | 40 |
|
|
2019
Q1 | $343K | Buy |
3,764
+185
| +5% | +$16.6K | 0.03% | 175 |
|
|
2018
Q4 | $326K | Buy |
3,579
+164
| +5% | +$15.3K | 0.04% | 170 |
|
|
2018
Q3 | $336K | Buy |
3,415
+2
| +0.1% | +$185 | 0.04% | 174 |
|
|
2018
Q2 | $292K | Buy |
3,413
+27
| +0.8% | +$2.25K | 0.03% | 192 |
|
|
2018
Q1 | $272K | Sell |
3,386
-703
| -17% | -$58K | 0.03% | 190 |
|
|
2017
Q4 | $330K | Sell |
4,089
-278
| -6% | -$22.3K | 0.04% | 170 |
|
|
2017
Q3 | $340K | Hold |
4,367
| – | – | 0.04% | 184 |
|
|
2017
Q2 | $388K | Buy |
4,367
+349
| +9% | +$29.4K | 0.05% | 163 |
|
|
2017
Q1 | $324K | Buy |
4,018
+372
| +10% | +$29.1K | 0.04% | 179 |
|
|
2016
Q4 | $260K | Sell |
3,646
-1,264
| -26% | -$99.3K | 0.04% | 189 |
|
|
2016
Q3 | $424K | Sell |
4,910
-455
| -8% | -$39.6K | 0.08% | 133 |
|
|
2016
Q2 | $466K | Sell |
5,365
-1,424
| -21% | -$115K | 0.08% | 144 |
|
|
2016
Q1 | $509K | Buy |
6,789
+3,793
| +127% | +$286K | 0.1% | 118 |
|
|
2015
Q4 | $230K | Sell |
2,996
-34,924
| -92% | -$2.63M | 0.05% | 187 |
|
|
2015
Q3 | $2.54M | Buy |
37,920
+29,035
| +327% | +$2.14M | 0.56% | 46 |
|
|
2015
Q2 | $658K | Buy |
8,885
+351
| +4% | +$26.8K | 0.13% | 111 |
|
|
2015
Q1 | $666K | Buy |
+8,534
| New | +$647K | 0.13% | 109 |
|
Other funds holding MDT
GW & Wade's MDT Position: Q4 2023 in Review
GW & Wade reduced its Medtronic (MDT) stake by 22% in Q4 2023, selling an estimated $2.25M and leaving 106,314 shares worth $8.76M. The position accounts for 0.28% of the portfolio, ranked #78.
GW & Wade first reported a position in MDT in Q1 2015 and has held it in 36 quarters since. The position peaked at $14.5M in Q3 2021. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.
- GW & Wade held 106,314 shares of Medtronic worth $8.76M as of Q4 2023.
- GW & Wade sold 29,575 Medtronic shares in Q4 2023, an estimated $2.25M.
- Medtronic made up 0.28% of GW & Wade's portfolio in Q4 2023, its #78 holding.
- GW & Wade first reported a position in Medtronic in Q1 2015 and has held it in 36 quarters since.
- GW & Wade's Medtronic position peaked at $14.5M in Q3 2021.
- 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.